Diffusion‐weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft‐tissue sarcomas
- 18 April 2008
- journal article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 27 (5), 1109-1113
- https://doi.org/10.1002/jmri.21358
Abstract
Purpose To determine if diffusion‐weighted imaging (DWI) can be used as a surrogate marker of tumor response to anticancer therapy in patients with soft‐tissue sarcomas. Materials and Methods Magnetic resonance imaging (MRI) including echo‐planar DWI sequences was performed prospectively in 23 consecutive patients with soft‐tissue sarcomas before and after initiation of regional or systemic chemotherapy. The mean interval between initial and follow‐up MRI was 56.9 ± 23.2 days. Tumor volumes were determined by manual segmentation of tumor borders on contrast‐enhanced T1‐weighted images. The apparent diffusion coefficient (ADC) was calculated from corresponding sections of ADC maps on initial and follow‐up DWI. Subsequently, changes in tumor volumes and ADC were correlated using the Pearson correlation coefficient. Results A high degree of correlation was found when changes in tumor volumes and ADC values were compared (r = −0.925, P < 0.0001), regardless of the effectiveness of anticancer therapy expressed as changes of tumor volume. Conclusion DWI can be used as a supplement to morphologic imaging for the evaluation of tumor response to anticancer therapy in patients with soft‐tissue sarcomas. As cellular changes are expected to precede morphologic changes in treated tumors, DWI performed at an early stage of fractionated therapy may provide unique prognostic information of its effectiveness. J. Magn. Reson. Imaging 2008;27:1109–1113.Keywords
This publication has 22 references indexed in Scilit:
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Soft‐tissue tumors evaluated by line‐scan diffusion‐weighted imaging: Influence of myxoid matrix on the apparent diffusion coefficientJournal of Magnetic Resonance Imaging, 2007
- Diffusion-weighted MR Imaging for Determination of Hepatocellular Carcinoma Response to Yttrium-90 RadioembolizationJournal of Vascular and Interventional Radiology, 2006
- The Functional Diffusion Map: An Imaging Biomarker for the Early Prediction of Cancer Treatment OutcomeNeoplasia, 2006
- Analysis of MR diffusion weighted imagesThe British Journal of Radiology, 2004
- Diffusion-weighted MRI of soft tissue tumoursEuropean Radiology, 2004
- Early Detection of Response to Radiation Therapy in Patients With Brain Malignancies Using Conventional and High b-Value Diffusion-Weighted Magnetic Resonance ImagingJournal of Clinical Oncology, 2003
- Diffusion‐weighted MRI in the characterization of soft‐tissue tumorsJournal of Magnetic Resonance Imaging, 2002
- Radiologic Evaluation of Soft-Tissue MassesAmerican Journal of Roentgenology, 2000
- Magnetic resonance imaging of soft tissue tumorsEuropean Radiology, 2000